The health and economic burden of endocrine disrupting chemicals, such as the plasticizer di(2-ethylhexyl) phthalate (DEHP), is prompting industry to develop alternatives. However, the absence of requirements for manufacturers to ensure the safety of these alternatives has led to the generation of replacements that may have similar or worse effects than the original chemicals. Consequently, there is increasing recognition by scientists, regulators and industry that proactive approaches are needed to develop safe chemical substitutes. We propose a 4-step approach for the design, characterization and toxicological testing of responsible alternative chemicals that we illustrate with our ongoing studies on DEHP replacements. Our approach is comprised of: (1) the design and characterization of alternative chemicals based on innovative chemical structures and environmental considerations; (2) large-scale in vitro cell-based high throughput and selective ex vivo studies to preselect the most innocuous alternatives; (3) an acute toxicity in vivo study to rule out overt toxicity of the selected candidates; and (4) an in utero and lactational exposure study comparing the effects of selected candidates to those currently in use, emphasizing commonly described phenotypes after exposure to the latter. Using this 4-step approach, we have identified 2 alternative chemicals displaying good plasticizing properties, better biodegradability, and less leaching than DEHP without any apparent toxicity in vivo. This process has thus far proven useful in the proactive identification of responsible chemical replacements for DEHP.
The global health burden of environmental pollutants has received wide recognition by the international scientific community during recent decades (Attina et al., 2016; Bellanger et al., 2015) . These pollutants include endocrine disrupting chemicals (EDCs), xenobiotics that alter the endocrine system and consequently cause adverse health effects in an intact organism or its progeny (Gore et al., 2015; IPCS, 2002) .
The potential health impact of EDCs such as phthalates, bisphenol A, and brominated flame retardants has led to a monumental public health movement encouraging governments to implement regulations and limit the use of these harmful chemicals. In response, industry has developed alternatives for use on the market; however, there is no requirement imposed on manufacturers, in any jurisdiction, to ensure that the replacement chemicals do not have the deleterious effect(s) associated with the original chemicals. Consequently, some of these replacements have proven to be regrettable, such as the bisphenol substitutes (eg, bisphenol F and bisphenol S) for the extensively studied bisphenol A.
There is increasing recognition by scientists, government regulators and industry that it is essential that safe chemicals be developed to replace those that are found to be harmful. We propose a proactive 4-step approach for the design, characterization and toxicological testing of responsible alternative chemicals ( Figure 1 ). We will use the possible replacement of the plasticizer di(2-ethylhexyl) phthalate (DEHP) as an example to illustrate this approach. Phthalates are used as plastic emollients, matrices, solvents and excipients in industrial applications (Heudorf et al., 2007) . Among them, DEHP is the most commonly used additive to provide flexibility to polyvinylchloride (PVC). It is found in countless consumer products, including construction materials, toys, packaging films and sheets, medical tubing and blood storage bags (Schettler, 2006) . Since phthalates are not covalently bound to their PVC supports, they leach out into the environment over time (Erythropel et al., 2014; Thomas and Thomas, 1984) ; numerous studies now report their ubiquitous presence in the environment (Fay et al., 1999; Fromme et al., 2002) and extensive human exposure (Hauser and Calafat, 2005; Koch et al., 2003; Silva et al., 2004; Wittassek et al., 2011) . Since the early 2000s, phthalates have been identified as antiandrogenic reproductive toxicant EDCs in both males and females; a number of in vitro, in vivo, ex vivo, and epidemiological studies indicate that phthalates have an adverse impact on testicular (Albert and Jé gou, 2014) and ovarian (Hannon and Flaws, 2015) development. More recent studies have also indicated that exposure to phthalates may have deleterious effects on the adrenal (Martinez-Arguelles and Papadopoulos, 2015), thyroid metabolism (Meeker et al., 2007) , obesity (Stojanoska et al., 2016) , and cognitive and behavioral development (Ejaredar et al., 2015) . The toxicity of DEHP and its stable monoester metabolite, mono(2-ethylhexyl) phthalate (MEHP), are believed to be in part conveyed by the interaction of the aromatic ring and alkyl side chains of DEHP and MEHP with peroxisome proliferator-activated receptors (PPARs) (Kambia et al., 2008) , nuclear receptor proteins that function as transcription factors regulating gene expression.
Hence, the first step of our approach is to design "green" chemicals that have good activity as plasticizers and have features such as biodegradation and low leachability to avoid environmental persistence. The second step is to screen these chemicals for their potential toxicity using in vitro cell and ex vivo culture-based approaches. The third step is to determine the biological effects of the chemicals selected as the top candidates in steps 1 and 2 in an in vivo acute exposure animal model. The fourth step is to investigate the possible EDC-targeted activity of the selected chemicals after in utero and lactational exposure in comparison to DEHP.
STEP 1: DESIGNING GREENER PLASTICIZERS
Synthesis: Chemists/Chemical Engineers The first step in the process is to develop new chemicals that partially or entirely reproduce the desirable properties of plasticizers found in phthalates. Although many approaches can be taken to produce "greener" plasticizers, the design and production of novel plasticizers led by the McGill University Department of Chemical Engineering were based on 2 prerequisites (Erythropel et al., 2012) . The first was to seek chemical families with good plasticizing potential that did not share major molecular features with DEHP. The second was to consider environmental factors, such as biodegradability and leachability.
The diesters of 3 small organic acids-succinic acid, fumaric acid, and their structural isomer, maleic acid, were considered as candidate chemicals (Erythropel et al., 2012) as previous studies identified small diesters to be suitable plasticizers (Van Veersen and Meulenberg, 1967) . Plasticizers synthesized from succinic acid also present the advantage of being produced from by-products of fermentation. Since phthalate synthesis requires the products of petroleum refinement, a shift towards succinic acid-based plasticizers reduces carbon offsets and the corresponding environmental footprint (Stuart et al., 2010) . Second generation dibenzoate plasticizers, proposed to address toxicity concerns previously raised by commercial diethylene-and dipropylene-glycol dibenzoate plasticizers (Firlotte et al., 2009) , were also included as potential alternatives. In total, 19 succinate-, fumarate-, maleate-, and dibenzoate-based plasticizers (Figure 2 ) with different side-chain lengths were produced.
The second prerequisite was to include environmental considerations in the decision process, as the majority of studies exploring alternatives have emphasized plasticizing properties with little regard for stability. Thus, candidate chemicals were also tested for biodegradability and leachability. These properties were compared with those of DEHP, as well as those of 1,2-cyclohexane dicarboxylic acid diisononyl ester (DINCH). DINCH, marketed as a safe phthalate replacement, was introduced to the European market in 2002 and received final approval from the European Food Safety Authority in 2006 despite a lack of peer-reviewed studies regarding its safety or potential toxicity (David et al., 2015) . Ubiquitous exposure to DINCH has been well documented since (Giovanoulis et al., 2016; Silva et al., 2013) , and suspicions of its toxicity have emerged (Campioli et al., 2015; Sheikh et al., 2016) .
Plasticizer Properties, Biodegradation, and Leachability DEHP, diethyl succinate, diethyl maleate, and dibutyl maleate were purchased from Sigma-Aldrich (Saint Louis, MO). All other compounds were synthesized using a Dean-Stark esterification (Erythropel et al., 2012) . Candidate chemicals were incorporated by extrusion into unplasticized PVC and tested as described by Erythropel et al. (2012) . Briefly, plasticizers were characterized by glass transition temperature, determined by temperature modulated differential scanning calorimetry, and the tensile strength of test bars. Biodegradability was assessed by exposing the microorganism Rhodococcus rhodocrous to various candidate chemicals, followed by gas chromatography assessment of metabolites. Leachability was assessed as described in Kastner et al. (2012) , using both gas chromatography and gravimetric analysis.
Overall, including DEHP and DINCH, 21 chemicals were tested ( Figure 2) ; the data that were generated from the chemical engineering evaluations (step 1) are summarized in color-coded Figure 3 . Most succinate-and dibenzoate-based plasticizers demonstrated good plasticizing properties and biodegradability (Erythropel et al., 2013) . Fumarate esters displayed poorer plasticizing properties. Maleate chemicals displayed potential as plasticizers but poorer biodegradation rates . Several candidates were found to minimize aqueous leaching to rates 10 times below that of DEHP, including some succinic-, maleic-, and dibenzoate-based candidates, as well as DINCH (Kastner et al., 2012) .
STEP 2: CELL AND EX VIVO-BASED APPROACHES TO DETERMINE THE TOXICITY OF ALTERNATIVE PLASTICIZER CHEMICALS
Immortalized Cell Lines A cell-based toxicity screening approach was used to select the most promising alternative plasticizers among the range of chemicals previously tested for their plasticizing properties, biodegradability, and leachability. In the National Academy of Sciences report entitled "Toxicity Testing in the Twenty-First Century" (National Research Council, 2007) , it was suggested that the development of innovative, sensitive, high-throughput testing strategies was essential to screen industrial chemicals for their possible adverse impacts on health. Since phthalates have been well established to adversely affect the development of the male genital tract, we tested the toxicity of our candidate chemicals on 10 different immortalized cell lines, covering the 3 major testicular cell types (the somatic Leydig and Sertoli cells and male germ cells) as well as prostatic epithelial cells (shown in Figure 4) . In a range of high-throughput toxicity screening assays, the cells were exposed for 24-48 h to concentrations of candidate chemicals ranging from 10 À9 to 10 À4 M in 96-well plates. The endpoints included: (1) cell viability assessment, using the MTT colorimetric assay for cell metabolic activity; (2) cell proliferation assessment, using classical or fluorescence-based 5-bromo-2 0 -deoxyuridine incorporation assays; (3) cell counts and morphology assessment, using complementary Hoechst (nuclear morphology), Calcein-AM (cellular morphology) and propidium iodide (nuclear integrity) fluorescent staining; (4) global gene expression assessment, using single color microarrays followed by qRT-PCR validation for selected genes and pathway analyses. Other cell-specific endpoints of interest were examined, such as steroid production and mitochondrial ultrastructure ( 
Ex Vivo Organotypic Culture
Since testicular function results from complex interactions between somatic and germ cells, ex vivo organotypic culture of testis explants, a well-established model for male reproductive toxicity (Chauvigné et al., 2009; Habert et al., 1991; Lassurguere et al., 2003) , was used to provide further insight into the effects of candidate chemicals and currently used plasticizers (Figure 4) . Briefly, gestational day (GD) 20 and postnatal day (PND) 3 rat testes were cut into explants and cultured on mesh for up to 4 days with or without hormonal stimulation, allowing for the assessment of tissue morphology, hormone-induced testosterone production, and cell proliferation. Both GD 20 and PND 3 correspond to hormone responsive states in the testis. At GD 20, gonocytes are quiescent, while at PND 3, they proliferate and start migrating towards the basement membrane of the newly formed testicular chords. Both time points are crucial for testicular development.
Results
The data generated during step 2 from the in vitro cell-based studies are summarized in Figure 3 . The dibenzoate and succinate plasticizer series were found to be the most promising with regard to their innocuity towards Leydig, male germ cell, Sertoli, and prostate cells, while maleate and fumarate based chemicals produced significant cell toxicity (Boisvert et al., 2016) . In particular, 1,4-butanediol dibenzoate (BDB) and dioctyl succinate (DOS) displayed the most interesting profiles with respect to the step 2 evaluations. This was confirmed using toxicogenomic approaches on the Sertoli TM4 (Nardelli et al., 2015) and the prostatic PNT1A cell lines (unpublished data) in which exposure to either of these chemicals had little or no effects on gene expression compared with MEHP ( Figure 3) . Interestingly, DINCH exerted a biphasic effect on steroid production in MA-10 and fetal Leydig cells (ex vivo testis explants), accompanied by a decrease in spermatogonial proliferation Figure 3 . Summary of data generated from step 1 (chemical engineering) and step 2 (in vitro toxicity) evaluations. For each criterion (top row) and each candidate molecule (first column), good candidates are indicated in green (light grey), acceptable candidates in blue (medium grey), and poor candidates in red (dark grey). The 2 candidates displaying the most innocuous profiles, DOS and BDB, are outlined. (Boisvert et al., 2016) , and clear bioactivity on the Sertoli TM4 cell line (Nardelli et al., 2015) , confirming the need to further explore its effects in vivo.
STEP 3: EFFECTS OF IN VIVO ACUTE EXPOSURE TO ALTERNATIVE PLASTICIZERS
Although both BDB and DOS displayed promising properties on the basis of cell and ex vivo assays, no information was available on their effects in vivo. Prior to undertaking studies to determine the possible developmental or reproductive toxicity of these chemicals, it was essential to determine whether they caused acute toxicity in rodents. To answer this question, we designed a repeated-dose 28-day acute systemic toxicity study in Sprague Dawley rats using an experimental design similar to that proposed in Organisation for Economic Co-Operation and Development (OECD) Test Guideline 407 (OECD, 2008) . All manipulation and terminal procedures were in accordance with protocol No. 5867 which was approved by the McGill University Animal Care Committee.
Briefly, 20 PND 21 Sprague Dawley male rats were purchased from Charles River Laboratories and acclimated for 7 days at the McGill University McIntyre Medical Sciences Building Animal Facility with food and water ad libitum. On PND29, the animals were randomly allocated to 1 of 5 treatment groups (corn oil, 15 or 150 mg/kg/d BDB or DOS) and gavaged by intubation for 28 consecutive days ( Figure 5A ).
Because there were no existing toxicokinetic data available for the test chemicals, the lower dosage was determined based on current phthalate exposure in the most exposed and vulnerable groups, such as neonates in intensive care units, with estimated exposure to DEHP on the order of 3 mg/kg/d for periods of weeks or months (U.S. Food and Drug Administration, 2001). When converted to the rat based on body weight and surface area (U.S. Food and Drug Administration, 2005), the dosage was increased to 18.6 mg/kg/d and rounded down to 15 mg/kg/d. The higher dose was determined based on OECD recommendations to select "the highest dose [. . .] with the aim of inducing toxic effects but not death or severe suffering", and to use "very large intervals (eg, more than a factor of 10) between dosages" (OECD, 2008).
Animals were weighed and abnormalities in behavior were monitored daily. Animals were euthanized after 28 days of exposure, on PND 58, at which point they have reached adult reproductive function. Blood was collected and serum prepared for chemical analysis. Vital organs (brain, heart, lung, liver, and kidneys), stress sensitive tissues (spleen, thymus, and adrenals) and reproductive tract tissues (testes, epididymides, ventral prostate, and seminal vesicles) were collected, weighed, and fixed for histological observations. BDB and DOS produced no significant effects on animal behavior or well-being. All standard endpoints for toxicological risk assessment, including organ weights (Figure 6 ), hematological endpoints and clinical biochemistry, remained unchanged by the treatments. Histopathological evaluation by an Step 2: In vitro and ex vivo toxicity approaches for the preselection of the best alternative chemicals. independent pathologist revealed very few anomalies (Table 1) ; the low incidences of hepatic lymphohistiocytic or renal lymphocytic inflammatory infiltrates and pyelonephritis that were observed were deemed to be due to background and unrelated to treatment. Overall, BDB and DOS did not produce overt toxicity. Together, these results indicated a lack of acute toxicity, thus allowing us to proceed to assessing the reproductive and developmental safety of these chemicals.
STEP 4: EFFECTS OF IN UTERO AND LACTATIONAL EXPOSURE TO ALTERNATIVE PLASTICIZERS
The final step that we undertook to assess the potential toxicity of novel plasticizers was to explore the possible endocrine disruptive properties of BDB or DOS after in utero and lactational exposure when compared with DEHP. The effects of phthalates such as DEHP on the development of the male reproductive system have been studied extensively (Albert and Jé gou, 2014) . Since the early 2000s research on EDCs has gained tremendous momentum from the conceptualization of the synchronized increasing prevalence of several male reproductive disorders-including genital abnormalities, testicular cancer, reduced semen quality and subfertility-, under the single entity known as testicular dysgenesis syndrome or TDS (Skakkebaek et al., 2001) . This phenotype was hypothesized to originate from a disruption of embryonic programming and gonadal development during fetal life, partly due to exposure to environmental factors. Since this, research on phthalates has been focused on male reproductive effects after in utero exposure. Thus, to explore whether BDB and DOS would display fewer endocrine disruptive properties than DEHP, we put a particular emphasis on endpoints that had previously been described to be altered by exposure to DEHP (Albert and Jé gou, 2014) .
The experimental approach we undertook was to treat pregnant Sprague Dawley rats with either vehicle or doses of each test chemical, eg, DEHP, DINCH, BDB or DOS, from GD 8 to PND 21 to encompass the full window of organogenesis, development, and postnatal lactational changes. Dosages were selected based on a literature search, with a high dose to match the average dose at which DEHP was shown to display effects after in utero and lactational exposure during this window of development, yet higher than the dose used in the acute toxicity study. The low dose was set at one-tenth of the higher dose.
Progeny were monitored throughout the study period for various developmental endpoints, including litter size, sex ratio, crown-rump length, pinnae detachment, anogenital distance, external malformations, incisor eruption, eye opening, nipple retention, and markers of the completion of puberty ( Figure 5B ). Pups were euthanized on PND 3, 8, 21, 46, or 90, key points in male and female gonadal development. Vital (heart, lung, liver, and kidneys), stress sensitive (spleen and adrenals) and reproductive tract (testes, epididymides, ventral prostate, seminal vesicles for males; ovaries, and uteri for females) tissues were collected, weighed, and stored for further histological and/or molecular analysis. Blood was collected and serum extracted on PND 21, 46, and 90 for hormonal analysis.
Dams presented with decreased heart weights after exposure to DEHP treatment (300 mg/kg). The only other effects observed in dams were decreases in serum alanine transaminase and magnesium after exposure to the lower dose of BDB; both findings were incompatible with liver or kidney damage, and the animals were otherwise healthy and gained weight) . In PND 3 male pups, DEHP induced a significant decrease in anogenital index and an increase in the incidence of multinucleated gonocytes, which have been classically described after exposure to antiandrogenic endocrine disruptive compounds. An increase in the incidence of hemorrhagic testes was also observed on PND 8 after exposure to the higher dose of DEHP and to both doses of DINCH, suggesting the need to further explore the effects of what is still marketed as a safe compound. More importantly, BDB and DOS produced no or negligible effects on both male and female pups up to PND 21 . These data suggest that both BDB and DOS are viable alternative plasticizers, and studies exploring the consequences of perinatal exposure to our candidate compounds on the adult reproductive function are underway.
CONCLUSION
To our knowledge, this approach constitutes the first systematic process for the design, characterization, and toxicological testing of responsible replacements for phthalate plasticizers. It consists of 4 consecutive steps: (1) the design and characterization of alternative chemicals based on chemical structures and environmental considerations; (2) a large scale in vitro cellbased high throughput and selective ex vivo studies to preselect the most innocuous alternatives; (3) an in vivo acute toxicity study to rule out overt toxicity of the selected candidates; and (4) an in utero and lactational exposure study comparing the effects of the selected candidates to those of the EDC being replaced, with an emphasis on commonly described phenotypes after exposure to the latter.
Using this 4-step approach, we have identified 2 alternatives, BDB, and DOS, that display good plasticizing properties, better biodegradability and less leaching than DEHP (step 1) in addition to a favorable profile in high throughput cell-based assays (step 2). BDB and DOS did not produce overt toxicity in vivo (step 3) or endocrine disruptive phenotypes after in utero and lactational exposure (step 4). Both BDB and DOS were produced using inexpensive starting materials and a process that would be easy to scale up (Erythropel et al., 2012) . DINCH, however, was found to be bioactive (Nardelli et al., 2015) and have endocrine disruptive properties (Boisvert et al., 2016; .
With an annual economic burden estimated at 340 billion dollars in the United States (Attina et al., 2016) and > 150 billion euros in Europe (Bellanger et al., 2015) , representing approximately 2% of the gross domestic product for both entities, endocrine disruptors have become one of the most prominent public health issues in modern societies. Although there is no such thing as a safe chemical, our observations confirm the validity of a proactive approach regarding the replacement of EDCs.
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